Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life.
Enrico LongatoBarbara Di CamilloGiovanni SparacinoLorenzo GubianAngelo AvogaroGian Poalo FadiniPublished in: BMJ open diabetes research & care (2021)
NCT04184947.
Keyphrases